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One-pot reaction between 8-hydroxyquinoline-2-carboxaldehyde (HQC) and tris(hydroxymethyl)aminomethane (TRIS) 
followed by in situ cyclization yielded an oxazolidine based ligand which produced four mononuclear complexes of MnII(1), 
CoII(2), NiII(3), ZnII(4), a tetranuclear iron (FeIII4) complex (5) and a trinuclear cobalt (Co
IICoIII2) complex (6). Magnetic studies 
show dominant antiferromagnetic interaction in tetranuclear iron (FeIII4) complex (5) and presence of the slow relaxation 
of magnetisation in 6 . The compounds were also studied for their antibacterial properties. The oxazolidine ligand (H3L2) of 
this study showed good antimicrobial activity not only against Gram-positive bacteria but also against Gram-negative 
bacteria. The antimicrobial efficacy of metal complexes (1-6) is also reported.  
 
 
Introduction 
Synthesis of polynuclear transition metal complexes has 
gained much attention in recent years due to their promising 
applications in single-molecule magnets (SMMs), quantum 
computing, and biomimetic catalysis.
1-4
 Use of polyalkoxy 
ligands is a widely accepted strategy to synthesize polynuclear 
coordination complexes.
5-11
 One of the popular ways to design 
new polyalkoxy ligands is through Schiff-base condensation 
between hydroxyaldehydes and aminoalcohols.
12-23
 In line with 
our interest in designing new polynuclear coordination 
complexes for studying magnetic and biomimetic properties, 
we coupled 8-hydroxyquinoline and 
tris(hydroxymethyl)aminomethane to design the desired 
Schiff-base ligand H4L1 (Scheme 1). However, the reaction 
between 8-hydroxyquinoline-2-carboxaldehyde (HQC) and 
tris(hydroxymethyl)aminomethane (TRIS) yielded an 
oxazolidine derivative by in situ cyclization, and produces H3L2 
during the synthesis. Conventionally oxazolidines can be 
synthesized by condensation of β-hydroxylamine and carbonyl 
compounds with loss of one molecule of water followed by a 
cyclization step.
24
 Oxazolidines are also synthesized by the 
reaction of aziridines with carbonyl compounds.
25
 Oxazolidines 
are well known for their interesting properties and widely used 
in asymmetric synthesis as chiral auxiliaries and has 
pharmacological applications due to their antimicrobial and 
anti epileptic properties. 
24, 26-31
 Use of oxazolidines as ligands 
have been observed in literature in past particularly for 
developing asymmetric catalysts. 
32-34
 8-hydroxyquinoline-2-
carboxaldehyde has been recently used with a range of amines 
to synthesize lanthanide based Schiff-base complexes. 
35, 36
 
Here we are reporting six new complexes of H3L2 with different 
transition metals, including three isostructural mononuclear 
six-coordinate complexes of Mn
II
(1), Co
II
(2), Ni
II
(3), one 
mononuclear five-coordinate complex of Zn
II
(4), a tetranuclear 
iron (Fe
III
4) complex (5) and a trinuclear cobalt (Co
II
Co
III
2) 
 
Scheme 1. Synthetic scheme of the desired ligand (H4L1) and the produced 
oxazolidine (H3L2) is shown with the proposed mechanism. 
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complex (6). All the complexes were characterized by single-
crystal X-ray diffraction, in combination with infrared (IR) 
spectroscopy, electrospray ionization mass spectroscopy (ESI-
MS), nuclear magnetic resonance (NMR) spectroscopy, 
thermogravimetric analyses (TGA), and elemental analyses. 
Antimicrobial activity of the complexes was tested against 
both gram-positive and gram-negative bacteria. Magnetic 
studies of the polynuclear complexes revealed that Compound 
6 shows frequency dependent slow relaxation of magnetism at 
2.5 K suggesting possible single-molecule magnet (SMM) 
behaviour. 
Experimental 
Materials and methods:  
8-Hydroxyquinoline-2-carboxaldehyde was purchased from 
Acros Organics and all the other chemicals were purchased 
from Sigma Aldrich and used without any further purification. 
All the solvents were purchased from Fisher Scientific and used 
as received. 
Elemental analyses (for C, H, and N) were carried out on a 
Perkin-Elmer 2400 series II analyzer. Fourier-transformed 
Infrared (FTIR) spectra were recorded over the range of 600-
4000 cm
-1
 using Perkin-Elmer Spectrum 100 FTIR spectrometer 
fitted with a Perkin-Elmer Universal ATR sampling device. 
Thermogravimetric analyses (TGA) were carried out using 
TAQ5000IR Thermogravimetric analyser (TA instrument). 
Nitrogen purging gas flow of 10 mL min
-1
 and 5 °C min
-1
 
heating ramp were used. A sample mass of approximately 5 
mg was used and TA Instruments Universal Analysis 2000 
software was employed to analyse the data. Electrospray 
ionization Mass Spectra (ESI-MS) were recorded using a 
Micromass Quattro Ultima Mass Spectrometer equipped with 
an electrospray ionization source, with a sample dissolved in 
methanol and injected at 10 μL/min. 
X-ray crystallography: Except for Compound 5 all data were 
collected with a Bruker D8 QUEST area detector diffractometer 
equipped with with MoKα radiation, a graded multilayer mirror 
-100 CMOS 
detector using an oil-coated shock-cooled crystal at 100(2) K. 
For Compound 5 data was collected with a Bruker APEX2 
diffractometer equipped with CuKα radiation, a graphite 
monochromator (  = 1.54184 Å) and an APEX2 detector using 
an oil-coated shock-cooled crystal at 173(2) K. A multi-scan 
correction for absorption was applied using the program 
SADABS (Bruker AXS Inc., 2016). The structure was solved by 
direct methods by using the program XT V2014/1 (Bruker AXS 
Inc., 2014) and refined by full matrix least squares procedures 
on F
2
 using SHELXL-2018/1 (Sheldrick, 2018).
37
 More details on 
X-ray data collection of each compound is provided at the 
Electronic Supplementary Information (ESI). 
NMR studies: Sample for H3L2 and Compound 4 were prepared 
in MeOD and in DMSO-d6 (Goss Scientific, UK), respectively, at 
concentrations of 15 mg/mL before transferred to field 
matched 5 mm NMR tubes (Wilmad, USA). 
1
H and 
13
C NMR 
spectra were acquired at 303 K on a Bruker AVIII 400 MHz 
spectrometer equipped with a 5 mm SMART probe operating 
at 400.153 and 100.629 MHz for 
1
H and 
13
C respectively. 
1
H
1
H-
COSY and 
1
H
13
C-HMBC spectra were collected in addition to 
the 1D data on Compound 4. Spectra were phased, referenced 
to the residual solvent signal and processed using TopSpin v. 
3.5pl7. 
Magnetic Studies: Dc magnetic susceptibility data (2-300 K) 
were collected on powdered samples using a SQUID 
magnetometer (Quantum Design MPMS-XL), applying a 
magnetic field of 0.1 T. All data were corrected for the 
contribution of the sample holder and the diamagnetism of 
the samples estimated from Pascal’s constants.
38, 39
 The 
magnetization measurements up to 5 T at 2-5 K. ac magnetic 
susceptibility was measured between 2 and 10 K with an 
oscillating field magnitude of 3.0 Oe and frequency ranging 
between 1 and 1488 Hz. The relaxation times were extracted 
from simultaneous fit of χ’ac and χ”ac using generalized Debye 
model.
40-44
  
Antimicrobial Studies: The in vitro antibacterial efficacy of the 
oxazolidine ligand; H3L2 and its complexes with different 
transition metals, including four mononuclear complexes of 
Mn
II
(1), Co
II
(2), Ni
II
(3), Zn
II
(4), a tetranuclear iron (Fe
III
4) 
complex (5) and a trinuclear cobalt (Co
II
Co
III
2) complex (6), 
were tested against both gram-positive and gram-negative 
 
(A) 
 
(B) 
Figure 1. The structure of Compound 1 (A) and Compound 4  (B) as determined by 
X-ray crystallography are shown. Colour code for the atoms: Blue (N), grey (C), red 
(O), purple (Mn), and yellow (Zn). 
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bacteria and in particular against the Staphylococcus (S.) 
aureus (NCTC 6571) and Escherichia (E.) coli (NCCTC 12923) 
strains. Most of the complexes were insoluble in common 
solvents including water, therefore, the antimicrobial activities 
of 1–6 complexes and that of the free ligand H3L2 were 
screened using the agar diffusion method.
45
  
The bacterial strains used in this study were stored at -70 °C. 
Both strains were sub-cultured on Tryptic Soya Agar (TSA) 
before testing. The inoculum to be tested was prepared by 
adjusting the turbidity of an overnight culture in water to an 
optical density at 550 nm equivalent to 5x10
8
 Colony Forming 
Units (CFUs)/mL, according to the McFarland standard, and 
spread on Müller-Hinton agar. Subsequently the Müller-Hinton 
agar plates were inoculated and the antimicrobial activity of 
0.5 mg of each compound was examined after overnight 
incubation at 37 °C. The antimicrobial activity of each 
compound was quantified by measuring the zone of inhibition 
in triplicate. 
Synthetic procedures  
[M
II
Cl(H2L2)(CH3OH)] (M = Mn, Co, Ni for 1, 2, and 3, 
respectively) and [Zn
II
Cl(H2L2)] (4): 8-Hydroxyquinoline-2-
carboxaldehyde (0.086 g, 0.5 mmol) and 
tris(hydroxymethyl)aminomethane (0.060 g, 0.5 mmol) were 
added to 20 mL of methanol and refluxed for 10 minutes. To 
the resulting yellow solution  2 mmol of the respective 
metal(II) chloride hexahydrate was added and  refluxed for 
another 20 minutes. The resulting solution was filtered while 
still hot in a glass vial and left to evaporate slowly at room 
temperature (approximately 20 °C). After a few days, 
crystalline products formed with yields of 24% for 
[Mn
II
Cl(H2L2)(CH3OH)] (1), 42% for [Co
II
Cl(H2L2)(CH3OH)] (2), 
22% for [Ni
II
Cl(H2L2)(CH3OH)] (3), and 26% for [Zn
II
Cl(H2L2)] (4) 
with respect to 8-Hydroxy-2-quinolinecarboxaldehyde. 
Elemental analyses; calc. (exp): (1): C, 45.30 (44.56); H, 4.82 
(3.97); N, 7.04 (6.56). (2): C, 44.85 (43.97); H, 4.77 (4.03); N, 
6.97(6.22). (3): C, 44.88(44.07); H, 4.77 (4.49); N, 6.98 (7.23). 
(4): C, 44.71 (43.87); H, 4.02 (4.21); N, 7.45 (6.34). IR (neat, cm
-
1
): (1) 3182 (m), 2948 (w), 2888 (w), 1570 (m), 1499 (m), 1450 
(s), 1383 (m), 1329 (m), 1265 (m), 1191 (w), 1137 (w), 1074 (s), 
1006 (s), 922 (m), 843 (s), 803 (w), 742 (m), 690 (w); (2) 3173 
(m), 2952 (w), 2888 (w), 1573 (m), 1499 (m), 1449 (s), 1388 
(m), 1332 (m), 1265 (s), 1190 (w), 1136 (w), 1079 (s), 1005 (s), 
959 (w), 927 (m), 842 (s), 745 (s), 690 (w); (3) 3176 (m), 2950 
(w), 2888 (w), 1576 (m), 1500 (m), 1448 (s), 1390 (m), 1330 
(m), 1265 (s), 1193 (w), 1137 (w), 1078 (s), 1003 (s), 959 (w), 
933 (m), 902 (w), 842 (s), 750 (s), 690 (w); (4) 3194 (m), 2954 
(w), 2889 (w), 1574 (m), 1500 (m), 11450 (s), 1388 (m), 1333 
(m), 1266 (m), 1228 (w), 1189 (w), 1074 (s), 1007 (s), 955 (w), 
925 (m), 896 (w), 843 (s), 746 (s), 690 (w);  
[Fe
III
4(O)(HL2)2(H3L3)2](NO3)2(CH3CN)2(5): 8-Hydroxyquinoline-
2-carboxaldehyde (0.086 g, 0.5 mmol), 
tris(hydroxymethyl)aminomethane (0.060 g, 0.5 mmol) and 
sodium acetate trihydrate (0.068 g, 0.5 mmol) were added to a 
mixture of 10 mL of methanol and 10 mL of acetonitrile and 
refluxed for 10 minutes. To the resulting solution iron(III) 
nitrate nonahydrate (0.130 g, 0.32 mmol) was added and the 
solution was refluxed for another 15 minutes. The resulting 
dark solution was filtered hot and left at room temperature 
(20 °C) for slow evaporation. Black crystals formed in three 
days with 46% yield with respect to 8-Hydroxy-2-
quinoliecarboxaldyhe. Elemental analyses for desolvated 5: 
calc. (exp): C, 50.87(48.12); H, 4.06(6.37); N, 10.38(8.29). IR: 
(5) IR (neat, cm
-1
): 3212 (b), 3076 (w), 2929 (w), 2879 (w), 1577 
(m), 1504 (m), 1465 (s), 1393 (m), 1332 (m), 1268 (m), 1179 
(w), 1083 (s), 1016 (m), 965 (w), 825 (m), 747 (s), 662 (w), 603 
(m); 
[Co
II
Co
III
2(HL2)2(μ
1
-N3)2(μ
2
-N3)2] (6): 8-Hydroxyquinoline-2-
carboxaldehyde (0.043 g, 0.25 mmol) and 
tris(hydroxymethyl)aminomethane (0.030 g, 0.25 mmol) were 
added to 20 mL of methanol and refluxed for 10 minutes. To 
the resulting yellow solution cobalt nitrate hexahydrate (0.291 
g, 1 mmol) and sodium azide (0.065 g, 1 mmol) were added 
and the solution was refluxed for another 30 minutes and 
filtered hot and left to cool. After a few days of slow 
evaporation at room temperature (approximately 20 °C), dark 
block shaped crystals formed with 42% yield with respect to 8-
Hydroxy-2-quinoliecarboxaldyhe. Elemental analyses; calc. 
(exp): C, 37.64(36.89); H, 3.16(2.78); N, 25.08(24.14). IR (neat, 
cm
-1
): (6) 3277 (w), 3067 (m), 2924 (w), 2864 (w), 2067 (s), 
2025 (s), 1581 (m), 1598 (w), 1461 (s), 1397 (m), 1363 (m), 
1283 (m), 1210 (m), 1178 (m), 1126 (s), 1030 (s), 970 (m), 846 
(m), 768 (s), 683 (m). 
Results and discussion 
All six complexes were synthesized in one-pot reactions. The 
ligands were synthesized in situ during the course of the 
reactions by refluxing a methanolic solution of 8-
hydroxyquinoline-2-carboxaldehyde and TRIS in equimolar 
ratio. To the resulting solution the metal salts were added 
(four equivalent) and refluxed further for 20 minutes. Slow 
evaporation of the filtered solutions at ambient condition 
yielded crystalline products of compounds 1-4 suitable for 
single-crystal X-ray measurements. For Compound 5 and 6 
sodium acetate and sodium azide were added as co-ligands, 
respectively. All the compounds were synthesized in methanol 
except for Compound 5 which was synthesized in a mixture of 
methanol and acetonitrile (1:1). 
Ligand: The condensation of HQC and TRIS did not produce the 
expected imine ligand H4L1, but further cyclized to form the 
oxazolidine ligand H3L2 as shown in Scheme 1. To check if the 
cyclization process requires the presence of the metal ions the 
synthesis of the ligand was carried out independently from the 
precursor amine and aldehyde in methanol under reflux 
condition and without addition of any metal salts. The 
resulting solution was dried under vacuum and the yellow 
product was characterized as H3L2 by IR, NMR, and ESI-MS (see 
S8, S15 and S17 in ESI). It proves that the presence of the 
metal ions is not a requirement for the cyclization process and 
formation of the oxazolidine ligand. However, any possible 
catalytic role of the metal ions is not ruled out and was not 
studied during this investigation. This form of the ligand (H3L2) 
coordinates the metal ions with four donor atoms and present 
ARTICLE Journal Name 
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in all six compounds (1-6). There is a second type of ligand that 
forms when H3L2 reacts with another equivalent of HQC to 
produce H5L3 (Scheme 2) with five coordinating groups on a 
plane. This ligand was found only in Compound 5. This form of 
the ligand was also previously reported by Yan et al. in a series 
of mononuclear lanthanoid complexes.
36
  
Structural description: Compounds 1 - 3 are isostructural and 
crystallize in monoclinic space group P21/n with a molecular 
formula of [M
II
Cl(H2L2)(CH3OH)] where M is Mn, Co, and Ni, for 
1, 2, and 3, respectively. Molecular structure of Compound 1 is 
shown in Figure 1A. The oxazolidine ligand (H3L2) satisfies four 
coordination sites of the metal ion, and three of the 
coordination bonds are through O1, N1, and N2 on the 
equatorial plane and the fourth alcoholic oxygen (O3) 
coordinates at the axial position. A chloride ion (Cl1) 
coordinates to the metal ion in the trans position to this 
alcoholic group, and a methanol satisfies the fourth 
coordination site (through O2) on the equatorial plane. It is 
worthnoting that there are two different kinds of hydroxyl 
groups in H3L2 and only the phenolic hydroxyl group is 
deprotonated. This can be easily explained by the higher 
acidity of phenolic groups compared to the primary alcohols 
due to the extra stability of the deprotonated form of phenolic 
hydroxyl groups gained through resonance. The bond 
distances between the metal ion and the coordinating atoms 
are given in Table 1. 
It can be clearly seen that the six coordination bonds are 
uneven in lengths  and the resulting geometry around the 
metal centres can be best described as slightly distorted 
octahedra. As a general trend the M-L bond distance decreases 
from Compound 1 to  Compound 3 as can be seen from Table 
1. Each molecule is bonded to six neighbouring molecules by 
inter-molecular hydrogen bonding, as shown in Figure S1 (see 
ESI). This extensive hydrogen bond networks assemble the 
molecules in a two-dimensional network, as shown in Figure 
S1. Compound 4 crystallizes in monoclinic space group P21/c 
with a molecular formula of [M
II
Cl(H2L2)]. Unlike compounds 1-
3, Compound 4 does not have the octahedral six coordinate 
geometry around Zn(II) ion. The coordination geometry of 
Zn(II) can be best described as distorted square pyramidal. The 
lack of preference to form octahedral complex for Compound 
4 is possibly due to no additional gain of crystal field 
stabilization energy (CFSE) for the d
10
 electronic configuration 
of Zn(II) ion. The tetranuclear iron compound, 
[Fe
III
4(O)(H2L2)2(H3L3)2] (NO3)2 (CH3CN)2 (5) was synthesized 
from a one-pot reaction from 8-Hydroxyquinoline-2-
carboxaldehyde, tris(hydroxymethyl)aminomethane, sodium 
acetate trihydrate, and iron(III) nitrate nonahydrate in a 1:1 
 mixture of methanol and acetonitrile. Compound 5 crystallizes 
in triclinic space group P-1. The compound has two different 
types of ligands, one being the H3L2 similar to compounds 1–4, 
and another form (H4L3) that forms from the condensation 
between H3L2 and 8- hydrxyquinoline-2-carboxaldehyde unit as 
shown in Scheme 2. There are two different kinds of iron (III) 
centres in the asymmetric unit of this compound, one is six-
coordinate (Fe2) and the other is seven-coordinate (Fe1). The 
coordination geometry for Fe2 is highly distorted octahedron 
as can be seen from Figure 2A. The structure can be best 
described by assuming Fe1 coordinated to a 
metallamacrocycle formed by Fe2 and one H3L2 and one H4L3 
Table 1. Selected bond lengths between the metal (Atom 1) and the 
coordinating atoms (Atom 2) are given for compounds 1 – 4 
Atom 
1 
Atom 
2 
(1) 
Length/Å 
(2) 
Length/Å 
(3) 
Length/Å 
(4) 
Length/Å 
M1 Cl1 2.4550(5) 2.4149(5) 2.3884(5) 2.2450(5) 
M1 O1 2.195(1) 2.119(1) 2.107(1) 2.071(1) 
M1 O2 2.142(1) 2.053(1) 2.047(1) - 
M1 O3 2.269(1) 2.171(1) 2.113(1) 2.002(1) 
M1 N1 2.181(1) 2.047(1) 1.979(1) 2.039(2) 
M1 N2 2.347(1) 2.210(1) 2.167(1) 2.273(2) 
(A) 
 
(B) 
Figure 2. (A) The structure of tetranuclear iron complex as determined by single 
crystal X-ray crystallography. (B) The structure of metallamacrocycle acting as a 
five coordinate ligand to bind the central Fe(III) in Compound 5. Colour code for 
the atoms: Blue (N), grey (C), red (O), orange (Fe).  
 
 
Scheme 2. Scheme showing the proposed pathway for the formation of H5L3. Red part 
is showing the atoms and bonds participating in the cyclization process. 
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as shown in Figure 2B. Two asymmetric units are linked via a 
linear μ
2
-oxo bridge (O1) as shown in Figure 2B. The Fe1 is 
coordinate to the five atoms of the metallamacrocycles, and 
Fe1 shares a plane with four coordinating atoms 
(N1N22O30O9) leaving N33 slightly above the plane. All the 
angles are listed in Table S5 in the ESI. Each molecule of 
Compound 5 is connected to the neighbouring molecules 
through hydrogen bonding and results into a porous three-
dimensional structure, with 5.9 % solvent accessible pore 
volume for a probe of 1.2 Å radius, as shown in Figure S2B in 
the ESI.
46
 
Reaction between 8-Hydroxyquinoline-2-carboxaldehyde, 
tris(hydroxymethyl)aminomethane, sodium azide, and cobalt 
nitrate hexahydrate produced a trinuclear cobalt complex, 
[Co
II
Co
III
2(HL2)2(η
1
-N3)2(μ
2
-1,1-N3)2] (6) (Figure 3). Compound 6 
crystallizes in a monoclinic space group P21/c with an 
asymmetric unit containing two cobalt atoms with different 
oxidation states, Co
III
, and Co
II
, respectively. Unlike the 
previous compounds (1-5), in compound 6 the ligand H3L2 
coordinates through all the available hydroxyl groups. The 
ligand coordinates to Co1 with five donor atoms and 
coordinates Co2 using one terminal hydroxy group and one 
deprotonated hydroxy group acts as a bridging group between 
Co1 and Co2. There are two different kinds of coordination for 
the azide groups in this complex, two terminal azide ligands 
coordinate to the two terminal Co1 metal centres, and two 
azides bridge between the central Co(II) and the terminal 
Co(III) atoms with μ
2
-1,1-N3 mode as as shown in Figure 3.
47
 
The coordination environment of the two types of cobalt 
atoms are very different. The terminal Co(III) centres have 
N4O2 coordination sphere, but the central Co(II) has a N2O4 
coordination sphere. Its worthnoting that relatively longer 
Co2-N2 bonds might be a result of Jahn-Teller distortion 
expected for a d
7
 low-spin configuration. The ∠Co1-N2-Co2 
and ∠Co1-O3-Co2 angles are 93.49(9) and 97.96(7), 
respectively. Each molecule is weakly bonded to the two 
neighbouring molecules through hydrogen bonding between 
the terminal azide units and the N-H group of the oxazolidine 
ring to form an one-dimension chain, as shown in Figure S3 in 
ESI. 
As a general observation it is worth noting that the 
mononuclear complexes formed only with +2 oxidation state 
of the first row transition metals (Mn, Co, Ni, and Zn), and 
polynuclear complexes were observed for metal ions with 
higher oxidation states and in presence of other co-ligands in 
this current study.  
Thermal stability: The thermal stability of all the compounds 
were tested using thermogravimentric analysis (TGA) and 
compound 1-3 shows a similar trend with three step 
decomposition with loss of the coordinate methanol molecule 
around approximately 200 °C at the first step, followed by 
another step around 275 °C which accounts the loss of one HCl 
molecule (for 2, observed loss: 9.40%, calculated: 8.90%), and 
the final decomposition around 400 °C without a distinct 
decomposition temperature. The residual mass is very close to 
the expected mass for the metal oxide. For example, for 
compound 2, the observed residual mass is 18.16 %, which is 
very close to the calculated mass of 18.65% for Co
II
O. 
Compound 5 shows approximately 4% mass loss around 75 °C 
possibly due to loss of lattice solvents (CH3CN) followed by 
another step-like decomposition around 150 °C followed by a 
gradual final decomposition starting around 250 °C to result 
into a residual mass of 18.84%. Compound 6 has an 
intermediate mass loss around 165 °C possibly due to the 
decomposition of the azide groups followed by a final 
decomposition at around 350 °C to form Co3O4 with an 
observed residual mass of 25.10% (calculated 26.95%). 
Infrared Spectroscopy: The IR spectra (see Figures S4-S7 in ESI) 
of compound 1 to 4 display a medium, sharp peak located at 
3182, 3173, 3176 and 3194 cm
-1
 for 1, 2, 3, and 4, respectively, 
indicative of N-H stretching, caused by the nitrogen 
coordinating with the metal ions. This band overlays a weaker, 
broad (3500 cm
-1
 to 3200 cm
-1
) peak, indicative of alcohol O-H 
stretching and interactions due to hydrogen bonding. 
Compound 5 displays a weak, broad O-H stretching band at 
3212 cm
-1
, whereas a weak, aromatic sp
2
 peak can be found at 
3076 cm
-1
. The two weak peaks present at roughly 2950 and 
2888 cm
-1
 in all five spectra are an indication of sp
3 
hybridized 
alkane C-H stretching. The medium, sharp peak present near 
1570 cm
-1
 on all five spectra can be identified as C=C aromatic 
stretching, along with the strong peak around 1450 cm
-1
, 
which can be attributed to aromatic C-C stretching. The 
medium, sharp peak between 1380 cm
-1
 and 1393 cm
-1
 can be 
interpreted as alkane C-H bending. The medium, sharp band 
found near 1330 cm
-1
 is indicative of C-N stretching, and the 
strong, sharp band present near 1070 cm
-1
 (1083 cm
-1
 in case 
of 5) can be ascribed to alcohol C-O stretching. For Compound 
6, the peak at 3277 cm
-1
 (w) is indicative of N-H stretching of a 
secondary amine. The band at 3067 cm
-1
 (m) indicates 
unsaturated sp
2
 hybridized C-H stretching, while the two weak 
saturated sp
3
 C-H stretching. The two strong, sharp peaks 2067 
cm
-1
 and 2025 cm
-1
 originating from the presence of N-N triple 
bonds of the terminal and bridging azide groups, respectively. 
The medium band at 1581 cm
-1
 and the strong band at 1461 
cm
-1
 can be attributed to aromatic C=C and C-C stretching 
respectively. The medium band at 1283 cm
-1
 indicates C-N 
 
Figure 3. The structure of Compound 6 as determined by single crystal X-ray 
crystallography is shown. Colour code for the atoms: Blue (N), grey (C), red (O), 
magenta (Co
II
), and dark-blue (Co
III
). 
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stretching, and the strong band at 1030 cm
-1 
can be assigned 
to the alcoholic C-O stretching. 
Electrospray ionization Mass Spectroscopy (ESI-MS): The 
isolated ligand (H3L2) and all six compounds (1-6) were 
analysed by ESI-MS (Figure S17 –S23 in ESI). The presence of 
the corresponding 
m
/z peaks suggests the existence of the 
singly charged entities (with +H
+
 or –Cl
-
) for the ligand, and the 
compounds 1 – 4. The presence of doubly charged 
[Fe
III
4(O)(H2L2)2(H3L3)2]
2+
 species was detected for Compound 5. 
However, the detection of any identifiable fragment for 
Compound 6 remained unsuccessful possibly due to the 
decomposition of the compound in solution or under ESI 
conditions. 
NMR studies: Attempt was made to look into the mechanism 
of formation of the ligand and to check if the presence of the 
metal ions is a requirement for the cyclization process. The 
ligand solution was evaporated at reduced pressure prior to 
addition of any metal ions, and the crystalline yellowish solid 
was analysed by NMR spectroscopy, which clearly showed the 
peaks corresponding to the oxazolidine ligand (see Figure S15 
in ESI), indicating that the presence of the metal ion is not a 
requirement for the cyclization process. However, any possible 
catalytic role of the metal ions is not excluded. The zinc 
complex (Compound 4) was also analysed with NMR 
spectroscopy and the peaks corresponding to the oxazolidine 
were assigned as shown in the 2D NMR spectra shown in 
Figure 4.  
Magnetic properties: The magnetic susceptibility 
measurements of compounds 5 and 6 were performed at 
variable temperature (2-300 K), at 0.1 T and the resulting χMT 
vs T plots are shown in Figure 5A. The magnetic susceptibility 
of Compound 5 is 9.32 cm
3
∙K∙mol
–1 
at 300 K is much smaller 
compared to the expected value of 17.514 cm
3
∙K∙mol
–1
 for four 
Fe
III
 (
6
A1g, S = 5/2, g = 2)
39
 suggests strong antiferromagnetic 
interactions. Due to dominant antiferromagnetic interaction at 
2 K the product of χMT have a value of 0.16 suggesting the 
ground spin state of S = 0. Based on the magnetostructural 
correlation the magnetic susceptibility data of 5 was 
analysed
48
 using the following Hamiltonian:  
H = -2J1(S1S2+S3S4)-2J2S2S3 
The best fit between theoretical and experimental data was 
obtained for J1 = -8.0 cm
-1
, J2 = -75.0 cm
-1
, and g = 2.03. The 
large value of coupling constant (J2) along μ-oxo bridge is 
consistent with similar cases previously reported on Fe
III
-O-Fe
III
 
geometry.
49
 
The susceptibility plot for Compound 6 is presented in Figure 
5B showing that the χMT value of 3.04 cm
3
∙K∙mol
–1
 at 300 K, 
which is consistent with the presence of one isolated 
paramagnetic Co(II) centre. Upon decreasing temperature, the 
χMT product continuously decreases and reach the value of 
2.00 cm
3
∙K∙mol
–1
 at 2 K. Such temperature dependence of the 
magnetic susceptibility is typical for mononuclear Co(II) 
 
Figure 4. NMR spectra (400 MHz) of Compound 4 in DMSO-d6 are shown: 
Selected area 1H, 1H COSY (top) and 1H, 13C HMBC spectrum (bottom). 
 
Figure 5. Temperature dependence of the χT product at Hdc = 0.1 T for Compound 
5 (A) and 6 (B). The solid line is simulated susceptibility according the model 
discussed in the text. Magnetization plot for Compound 6 is given (inset B) at 
different temperatures. 
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compounds and is related to presence of important magnetic 
anisotropy.
50-53
 
To determine the anisotropy parameters the magnetization 
plot (Figure 5B, inset) was fitted using the following 
Hamiltonian: 
54
 
𝐻 = 𝐷𝑆𝑧
2 + 𝐸(𝑆𝑥
2 − 𝑆𝑦
2) + 𝑔𝜇𝐵𝑆𝐵                
Where D, E and g stand for the axial and rhombic zero-field 
splitting (ZFS) parameters and the isotropic Landé factor of the 
S spin state, µB and B stand for the Bohr magneton and 
magnetic field, respectively. The parameters obtained for best 
fit are D = - 25.65 cm
-1
 E = 3.42 cm
-1
 and g = 2.70 (R = 7.8×10
-3
). 
Dynamic magnetic properties of the trinuclear cobalt complex 
(6) were investigated. At zero dc field, no out-of-phase (χ”ac) 
signal was observed. Applying a small dc field of 2000 Oe a 
signal in χ”ac can be detected. The ac data were fitted using an 
extended Debye model
42-44
 for two relaxation processes 
(Figure 6). The model with one relaxation process does not 
give satisfactory fit. The presence of two relaxation process in 
several mononuclear Co(II) complexes have been previously 
observed.
55-59
  
The analysis of temperature dependence of relaxation times at 
dc field of 2000 Oe reveal an energy barrier of slow magnetic 
relaxation of 5.1 K with τ0 = 2*10
-5 
(see figure S24 in ESI)
 
which 
is much smaller than the zero-field energy gap of magnitude 
2D as predicted by the static magnetic measurements. This 
discrepancy excludes the Orbach relaxation process and 
suggests the direct spin phonon relaxation or Raman 
mechanism of relaxation in 6.
60-62
  
Antimicrobial studies:  
Bacterial resistance development has become a serious clinical 
problem for many classes of antibiotics. Oxazolidinones are a 
unique class of synthetic antibiotics, that are active mainly 
against Gram-positive organisms, but they also display modest 
activity against certain gram negative. The effect of the 
presence of the ligand H3L2 and all six complexes (1-6) on the 
bacterial growth on the Müller-Hinton agar plates is shown in 
Figure S25 in the ESI. The antibacterial activity of the ligand 
and its complexes against S. aureus and E. coli is presented as 
zone of inhibition in mm, and the results are given in Table 2.  
It can be clearly seen that the oxazolidine ligand (H3L2) shows 
substantial antimicrobial activity against both bacterial strains. 
Compounds 1-4 show antimicrobial activity but this is reduced 
in comparison to the ligand and this depends on the metal and 
the complex that has been formed. In particular, Compound 1, 
followed by Compound 4 show better antimicrobial efficacy 
against S. aureus than E. coli. Complexes 2 and 3 show 
comparable activity against both S. aureus and E. coli but this 
is significantly reduced in comparison to the ligand and the 
compounds 1 and 4. Compounds 5 and 6 do not show any 
antimicrobial activity against either of the strains. 
Oxazolidinones are well known for their efficacy against Gram-
positive bacteria.
63
 The produced oxazolidine (ligand) of this 
study showed good antimicrobial activity not only against 
Gram-positive bacteria but against Gram-negative too. The 
antimicrobial efficacy testing of metal (Mn, Fe, Co, Ni, Cu) 
chelates of 1, 2-naphthoquinone 2-oxime has shown that Mn 
complex is more potent than Cu complex and these two are 
more potent than Co and Ni complexes, in an order that 
agrees with the finding of Jadav et al.,
64
 while the iron(III) 
complex did not show any activity against Gram-positive 
bacteria but did against Gram-negative bacteria. The results 
indicate that the antimicrobial properties are possibly 
originating from the ligand H3L2 only, and persist in presence 
of M
2+
 ions. However, the antimicrobial properties are lost 
when the ligand is coordinate to metal ions with higher 
oxidation state (+3 here). One possible explanation may be 
due to less availability of the free ligands due to stronger 
Table 2. Zones of inhibition in mm of ligand   H3L2 and its complexes; 1 – 6 
Compound H3L2 (1) (2) (3) (4) (5) (6) 
S. aureus 34±1.6 23.3±1.3 13.3±0.5 3.7±0.5 18±0.8 0±0 0±0 
E. coli 
20.3±0.5 5±0.8 11.7±0.5 6.7±0.5 11.3±0.9 0±0 0±0 
 
Figure 6. Frequency dependence of χ’ac (top), χ”ac (middle), and Cole-Cole plot (χ’ac 
vs. χ”ac)  (bottom) are shown at different temperatures (2 – 4.5 K) for Compound 6. 
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binding with the higher oxidation state metal ions. 
Conclusions 
In summary, a new oxazolidine based ligand H3L2 has been 
synthesized by in situ cyclization, and its four mononuclear 
complexes of Mn
II
, Co
II
, Ni
II
, and Zn
II
, a tetranuclear Fe
III
4 
complex, and a trinuclear Co
III
-Co
II
-Co
III
 complex (Compound 1-
6, respectively) have been synthesized. Magnetic properties of 
the polynuclear complexes (5, and 6) have been studied in 
detail. The dominant antiferromagnetic interaction was found 
in the case of Compound 5 (J1 = -8.0 cm
-1
 J2 = -75.0 cm
-1
 g = 
2.03). Compound 6 has behaviour typical for isolated 
paramagnetic Co
II
 centre in octahedral environment and show 
slow relaxation of magnetisation at 2 K. The oxazolidine ligand 
(H3L2) of this study showed good antimicrobial activity not only 
against Gram-positive bacteria but also against Gram-negative 
bacteria. The antimicrobial efficacy of the metal complexes (1-
6) is also reported.  
Conflicts of interest 
There are no conflicts to declare. 
Acknowledgements 
SN thanks Royal Society of Chemistry for a Research Fund 
award, and University of Bradford for research facilities. A 
fruitful discussion with Dr Małgorzata Hołyńska is kindly 
acknowledged. 
Notes and references 
1 A. M. Ako, I. J. Hewitt, V. Mereacre, R. Clerac, W. 
Wernsdorfer, C. E. Anson and A. K. Powell, Angew. Chem., Int. 
Ed., 2006, 45, 4926-4929. 
2 L. Bogani and W. Wernsdorfer, Nat. Mater., 2008, 7, 179-
186. 
3 C. J. Milios, A. Vinslava, W. Wernsdorfer, S. Moggach, S. 
Parsons, S. P. Perlepes, G. Christou and E. K. Brechin, J. Am. 
Chem. Soc., 2007, 129, 2754-2755. 
4 J. S. Kanady, E. Y. Tsui, M. W. Day and T. Agapie, Science, 
2011, 333, 733-736. 
5 E. E. Moushi, T. C. Stamatatos, W. Wernsdorfer, V. 
Nastopoulos, G. Christou and A. J. Tasiopoulos, Inorg. Chem., 
2009, 48, 5049-5051. 
6 M. Murugesu, J. Raftery, W. Wernsdorfer, G. Christou and E. 
K. Brechin, Inorg. Chem., 2004, 43, 4203-4209. 
7 S. Nayak, G. aromi, S. J. Teat, J. R. Ariño, P. Gamez and J. 
Reedijk, Dalton Trans., 2010, 39, 4986-4990. 
8 S. Nayak, L. M. C. Beltran, Y. Lan, R. Clérac, N. G. R. Hearns, 
W. Wernsdorfer, C. E. Anson and A. K. Powell, Dalton Trans., 
2009, 1901-1903. 
9 Y. Xie, H. Jiang, A. S.-C. Chan, Q. Liu, X. Xu, C. Du and Y. Zhu, 
Inorg. Chim. Acta, 2002, 333, 138-143. 
10 Y. Xie, W. Bu, A. S.-C. Chan, X. Xu, Q. Liu, Z. Zhang, J. Yu and 
Y. Fan, Inorg. Chim. Acta, 2000, 310, 257-260. 
11 Y. Xie, J. Ni, F. Zheng, Y. Cui, Q. Wang, S. W. Ng and W. Zhu, 
Cryst. Growth Des., 2009, 9, 118-126. 
12 S. Nayak, A. Pevec, C. C. Seaton, P. Gamez and J. Reedijk, 
Polyhedron, 2016, 107, 172-175. 
13 S. Nayak, H. P. Nayek, S. Dehnen, A. K. Powell and J. Reedijk, 
Dalton Trans., 2011, 40, 2699-2702. 
14 Y. Lan, G. Novitchi, R. Clerac, J. K. Tang, N. T. Madhu, I. J. 
Hewitt, C. E. Anson, S. Brooker and A. K. Powell, Dalton Trans., 
2009, 0, 1721-1727. 
15 H. Miyasaka, R. Clerac, T. Ishii, H. C. Chang, S. Kitagawa and 
M. Yamashita, J. Chem. Soc.-Dalton Trans., 2002, 0, 1528-1534. 
16 Z. Lü, M. Yuan, F. Pan, S. Gao, D. Zhang and D. Zhu, Inorg. 
Chem., 2006, 45, 3538-3548. 
17 D. Dragancea, N. Talmaci, S. Shova, G. Novitchi, D. 
Darvasiová, P. Rapta, M. Breza, M. Galanski, J. Kožıš́ek, N. M. R. 
Martins, L. M. D. R. S. Martins, A. J. L. Pombeiro and V. B. Arion, 
Inorg. Chem., 2016, 55, 9187-9203. 
18 L.-L. Hu, Z.-Q. Jia, J. Tao, R.-B. Huang and L.-S. Zheng, Dalton 
Trans., 2008, 0, 6113-6116. 
19 Z.-Q. Jia, X.-J. Sun, L.-L. Hu, J. Tao, R.-B. Huang and L.-S. 
Zheng, Dalton Trans., 2009, 0, 6364-6367. 
20 C. Ding, C. Gao, S. Ng, B. Wang and Y. Xie, Che. Eur. J., 2013, 
19, 9961-9972. 
21 C.-X. Ding, J. Ni, Y.-H. Yang, S.-W. Ng, B.-W. Wang and Y.-S. 
Xie, Crystengcomm, 2012, 14, 7312-7319. 
22 S. Nayak, G. Novitchi, S. Muche, D. Luneau and S. Dehnen, Z. 
Aorg. Allg. Chem. , 2012, 638, 1127-1133. 
23 S. Nayak, O. Roubeau, S. Teat, C. Beavers, P. Gamez and J. 
Reedijk, 2010, 49, 216-221. 
24 E. D. Bergmann, Chem. Rev., 1953, 53, 309-352. 
25 S. Gandhi, A. Bisai, B. A. B. Prasad and V. K. Singh, 2007, 72, 
2133-2142. 
26 C. Agami and F. Couty, Eur. J. Org. Chem., 2004, 2004, 677-
685. 
27 C. W. Ford, J. C. Hamel, D. M. Wilson, J. K. Moerman, D. 
Stapert, R. J. Yancey Jr, D. K. Hutchinson, M. R. Barbachyn and S. 
J. Brickner, Antimicrob. Agents Chemother., 1996, 40, 1508-
1513. 
28 E. A. Swinyard, W. C. Brown and L. S. Goodman, J. Pharm. 
Exp. Ther., 1952, 106, 319-330. 
29 G. Desimoni, G. Faita and K. A. Jørgensen, Chem. Rev., 2006, 
106, 3561-3651. 
30 L. M. Geary and P. G. Hultin, Tetrahedron, 2009, 20, 131-173. 
31 G. A. Ardizzoia, S. Brenna and B. Therrien, Dalton Trans., 
2012, 41, 783-790. 
32 R. W. Saalfrank, H. Maid, F. Hampel and K. Peters, Eur. J. 
Inorg. Chem., 1999, 1999, 1859-1867. 
33 C. Ding, F. Zeng, J. Ni, B. Wang and Y. Xie, Cryst. Growth Des., 
2012, 12, 2089-2096. 
34 C. Wolf and H. Xu, Chem. Commun., 2011, 47, 3339-3350. 
35 F. Duan, L. Liu, C. Qiao and H. Yang, Inorg. Chem. Commun., 
2015, 55, 120-122. 
36 M. Zhang, H. Li, P. Chen, W. Sun, L. Zhang and P. Yan, J. Mol. 
Str., 2015, 1081, 233-236. 
37 G. M. Sheldrick, Acta Crystallogr. Sect. A, 2008, 64, 112-122. 
38 P. Pascal, Ann. Chim. Phys., 1910, 19, 5-13. 
39 O. Kahn, Molecular Magnetism, Wiley-VCH, 1993. 
40 C. Dekker, A. F. M. Arts, H. W. Wijn, A. J. van Duyneveldt and 
J. A. Mydosh, Phys. Rev. B., 1989, 40, 11243-11251. 
41 K. S. Cole and R. H. Cole, J. Chem. Phys., 1941, 9, 341-351. 
42 Y.-N. Guo, G.-F. Xu, Y. Guo and J. Tang, Dalton Trans., 2011, 
40, 9953-9963. 
43 Y. N. Guo, G. F. Xu, W. Wernsdorfer, L. Ungur, Y. Guo, J. K. 
Tang, H. J. Zhang, L. F. Chibotaru and A. K. Powell, J. Am. Chem. 
Soc., 2011, 133, 11948-11951. 
44 Y.-N. Guo, G.-F. Xu, P. Gamez, L. Zhao, S.-Y. Lin, R. Deng, J. 
Tang and H.-J. Zhang, J. Am. Chem. Soc., 2010, 132, 8538-8539. 
45 J. Han, M. E. Castell-Perez and R. G. Moreira, WT-Food Sci. 
Technol., 2007, 40, 1545-1554. 
46 C. F. Macrae, I. J. Bruno, J. A. Chisholm, P. R. Edgington, P. 
McCabe, E. Pidcock, L. Rodriguez-Monge, R. Taylor, J. van de 
Streek and P. A. Wood, J. Appl. Crystallogr., 2008, 41, 466-470. 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 9  
Please do not adjust margins 
Please do not adjust margins 
47 Y.-F. Zeng, X. Hu, F.-C. Liu and X.-H. Bu, Chem. Soc. Rev., 
2009, 38, 469-480. 
48 J. J. Borras-Almenar, J. M. Clemente-Juan, E. Coronado and B. 
S. Tsukerblat, J. Comp. Chem., 2001, 22, 985-991. 
49 S. M. Gorun and S. J. Lippard, Inorg. Chem., 1991, 30, 1625-
1630. 
50 J. Titiš and R. Boča, Inorg. Chem., 2011, 50, 11838-11845. 
51 J. Titiš, J. Hudák, J. Kožíšek, A. Krutošíková, J. Moncol’, D. 
Tarabová and R. Boča, Inorg. Chim. Acta., 2012, 388, 106-113. 
52 B. Papánková, R. Boča, Ľ. Dlháň, I. Nemec, J. Titiš, I. Svoboda 
and H. Fuess, Inorg. Chim. Acta., 2010, 363, 147-156. 
53 C. Rajnák, J. Titiš, R. Boča, J. Moncol’ and Z. Padělková, 
Monatsh. Chem., 2011, 142, 789-795. 
54 M. P. Shores, J. J. Sokol and J. R. Long, J. Am. Chem. Soc., 
2002, 124, 2279-2292. 
55 E. A. Buvaylo, V. N. Kokozay, O. Y. Vassilyeva, B. W. Skelton, 
A. Ozarowski, J. Titiš, B. Vranovičová and R. Boča, Inorg. Chem., 
2017, 56, 6999-7009. 
56 C. Rajnak, F. Varga, J. Titis, J. Moncol and R. Boca, Eur. J. 
Inorg. Chem., 2017, 1915-1922. 
57 C. Rajnak, J. Titis, O. Fuhr, M. Ruben and R. Boca, Inorg. 
Chem., 2014, 53, 8200-8202. 
58 A. V. Palii, D. V. Korchagin, E. A. Yureva, A. V. Akimov, E. Y. 
Misochko, G. V. Shilov, A. D. Talantsev, R. B. Morgunov, S. M. 
Aldoshin and B. S. Tsukerblat, Inorg. Chem., 2016, 55, 9696-
9706. 
59 R. Boca, J. Miklovic and J. Titis, Inorg. Chem., 2014, 53, 2367-
2369. 
60 Y.-Z. Zhang, S. Gomez-Coca, A. J. Brown, M. R. Saber, X. 
Zhang and K. R. Dunbar, Chem. Sci., 2016, 7, 6519-6527. 
61 V. V. Novikov, A. A. Pavlov, Y. V. Nelyubina, M.-E. Boulon, O. 
A. Varzatskii, Y. Z. Voloshin and R. E. P. Winpenny, J. Am. Chem. 
Soc.,, 2015, 137, 9792-9795. 
62 E. Colacio, J. Ruiz, E. Ruiz, E. Cremades, J. Krzystek, S. 
Carretta, J. Cano, T. Guidi, W. Wernsdorfer and E. K. Brechin, 
Angew. Chem. Int. Ed., 2013, 52, 9130-9134. 
63 M. F. Gordeev and Z. Y. Yuan, J. Med. Chem., 2014, 57, 4487-
4497. 
64 V. B. Jadhav, H. P. Desimukh, N. R. Gonewar, K. D. Jadhav 
and R. G. Sarawadekar, Int. J. Chem. Sci., 2013, 11, 1286-1298. 
Journal Name  
ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 10  
Please do not adjust margins 
Please do not adjust margins 
 
Table 3. Crystallographic data for compounds 1 – 6. 
Compound 1 2 3 4 5 6 
CCDC reference no. 1832155 1832156 1832157 1832158 1588548 1832159 
Empirical formula C15H19ClMnN2O5 C15H19ClCoN2O5 C15H19ClN2NiO5 C14H15ClN2O4Zn C80H76Fe4N14O27 C28H28Co3N16O8 
Formula weight 397.71 401.70 401.48 376.10 1888.94 893.45 
Temperature/K 100(2) 100(2) 100(2) 100(2) 173(2) 100(2) 
Crystal system monoclinic monoclinic monoclinic monoclinic triclinic monoclinic 
Space group P21/n P21/n P21/n P21/c P-1 P21/c 
a/Å 13.1683(5) 13.1024(5) 13.0791(5) 11.0694(5) 11.9096(6) 9.4740(4) 
b/Å 8.5529(3) 8.5218(3) 8.4696(3) 9.1258(4) 12.5269(7) 17.7982(6) 
c/Å 14.3906(6) 14.1371(6) 14.1012(5) 13.8053(6) 17.0352(10) 9.7057(4) 
α/° 90 90 90 90 83.424(4) 90 
β/° 91.695(2) 90.3820(10) 90.0920(10) 91.676(2) 81.197(5) 97.4270(10) 
γ/° 90 90 90 90 69.805(4) 90 
Volume/Å3 1620.06(11) 1578.46(11) 1562.05(10) 1393.98(11) 2351.9(2) 1622.85(11) 
Z 4 4 4 4 1 2 
ρcalcg/cm
3 1.631 1.690 1.707 1.792 1.334 1.828 
μ/mm-1 1.008 1.286 1.443 1.974 5.522 1.595 
F(000) 820.0 828.0 832.0 768.0 974.0 906.0 
Crystal size/mm3 0.380 × 0.170 × 0.160 0.271 × 0.138 × 0.102 0.140 × 0.140 × 0.080 0.340 × 0.082 × 0.032 0.65 × 0.34 × 0.32 0.16 × 0.12 × 0.11 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) CuKα (λ = 1.54184) MoKα (λ = 0.71073) 
2Θ range for data 
collection/° 
5.542 to 55.062 5.582 to 55.024 4.25 to 55.05 5.352 to 55.046 5.262 to 134.142 4.812 to 52.814 
Index ranges 
-17 ≤ h ≤ 17, -10 ≤ k ≤ 
11, -18 ≤ l ≤ 18 
-17 ≤ h ≤ 17, -9 ≤ k ≤ 
11, -18 ≤ l ≤ 18 
-16 ≤ h ≤ 16, -11 ≤ k ≤ 
11, -18 ≤ l ≤ 18 
-14 ≤ h ≤ 14, -11 ≤ k ≤ 
10, -17 ≤ l ≤ 17 
-14 ≤ h ≤ 13, -14 ≤ k ≤ 
14, -20 ≤ l ≤ 18 
-11 ≤ h ≤ 11, -22 ≤ k 
≤ 21, -12 ≤ l ≤ 12 
Reflections collected 20227 16727 20426 17433 10875 21623 
Independent 
reflections 
3715 [Rint = 0.0337, 
Rsigma = 0.0246] 
3618 [Rint = 0.0274, 
Rsigma = 0.0232] 
3590 [Rint = 0.0253, 
Rsigma = 0.0201] 
3200 [Rint = 0.0362, 
Rsigma = 0.0268] 
7709 [Rint = 0.0619, 
Rsigma = 0.1347] 
3319 [Rint = 0.0482, 
Rsigma = 0.0299] 
Data/restraints/param
eters 
3715/1/235 3618/0/235 3590/0/235 3200/0/211 7709/895/727 3319/58/276 
Goodness-of-fit on F2 1.034 1.055 1.077 1.038 0.974 1.024 
Final R indexes 
[I>=2σ (I)] 
R1 = 0.0291, wR2 = 
0.0660 
R1 = 0.0286, wR2 = 
0.0649 
R1 = 0.0283, wR2 = 
0.0645 
R1 = 0.0267, wR2 = 
0.0589 
R1 = 0.0702, wR2 = 
0.1676 
R1 = 0.0335, wR2 = 
0.0791 
Final R indexes [all 
data] 
R1 = 0.0379, wR2 = 
0.0696 
R1 = 0.0363, wR2 = 
0.0682 
R1 = 0.0330, wR2 = 
0.0667 
R1 = 0.0354, wR2 = 
0.0623 
R1 = 0.1071, wR2 = 
0.1813 
R1 = 0.0466, wR2 = 
0.0851 
Largest diff. 
peak/hole / e Å-3 
0.42/-0.36 0.45/-0.41 0.49/-0.39 0.69/-0.43 0.68/-0.92 0.57/-0.46 
